ArticleJournal of translational medicine2025

A macro-micro-macro radiogenomic framework identifies FIBCD1 as a key immune-modulating biomarker in breast cancer.

Minping Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.